<DOC>
	<DOCNO>NCT01860157</DOCNO>
	<brief_summary>In study , investigator examine effect deep repetitive transcranial magnetic stimulation ( rTMS ) use H1 coil patient age 60 unable tolerate fail respond antidepressant medication . The coil design stimulate deeper region leave DLPFC . The investigator propose active stimulation H1 coil result high remission rate placebo stimulation similar tolerability safety profile .</brief_summary>
	<brief_title>Deep rTMS Treatment-Resistant Late-life Depression</brief_title>
	<detailed_description>This study randomize double blind , sham control study evaluate safety efficacy H1-coil rTMS treatment patient 60 year age major depressive disorder tolerate failed respond antidepressant medication . The study duration 4-6 week length . The acute phase 4 week 5 daily treatment follow 2 week biweekly treatment remission achieve 4 week mark . Symptom change remission criterion assess use HRDS-24 item . Cognition assess use validated battery .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>outpatient voluntary competent consent treatment SCID DSMIV confirm diagnosis major depressive disorder , single recurrent age 60 85 fail achieve clinical response adequate dose antidepressant base ATHF score ≥ 3 current episode OR unable tolerate least 2 separate trial antidepressant inadequate dose duration ( ATHF 1 2 ) score ≥ 22 HDRS24 increase initiation psychotropic medication 4 week prior screen able adhere treatment schedule pas TMS safety screen questionnaire normal thyroid function base prestudy blood work history DSMIV substance dependence abuse within last 3 month concomitant major unstable medical illness , cardiac pacemaker implant medication pump acutely suicidal pregnant lifetime SCID diagnosis Bipolar I II disorder , schizophrenia , schizoaffective disorder , schizophreniform disorder , delusional disorder , current psychotic symptom SCID diagnosis obsessive compulsive disorder , posttraumatic stress disorder ( current within last year ) , anxiety disorder ( generalize anxiety disorder , social anxiety disorder , panic disorder ) assess study investigator primary causing great impairment MDD SCID diagnosis personality disorder assess study investigator primary causing great impairment MDD presume probably dementia , define Mini Mental Status Exam ( MMSE ) &lt; 26 clinical evidence dementia fail course ECT within current depressive episode significant neurological disorder insult , include , limited : condition likely associate increase intracranial pressure , space occupy brain lesion , history seizure except therapeutically induced ECT , cerebral aneurysm , Parkinson 's disease , Huntington 's chorea , multiple sclerosis , significant head trauma loss consciousness great equal 5 minute dose Buprioprion great 300mg per day intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , electrode ) metal object within near head , exclude mouth , safely remove participate psychotherapy , must stable treatment least 3 month prior entry study , anticipation change frequency therapeutic session , therapeutic focus duration study clinically significant laboratory abnormality , opinion investigator currently ( last 4 week ) take lorazepam 2 mg daily ( equivalent ) dose anticonvulsant due potential limit rTMS efficacy inability communicate English noncorrectable clinically significant sensory impairment ( i.e hear well enough cooperate interview )</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>rTMS</keyword>
	<keyword>depression</keyword>
	<keyword>magnetic</keyword>
</DOC>